Know Cancer

or
forgot password

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities


N/A
18 Years
80 Years
Open (Enrolling)
Both
Glioblastoma Multiforme

Thank you

Trial Information

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities


Inclusion Criteria:



- The presence of a primary brain tumor that cannot be completely resected that
requires radiation therapy with or without chemotherapy.

Exclusion Criteria:

- Patients who do not have a primary brain tumor or who are unable to tolerate the
environment of the MRI scanner

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To detect the early "local" treatment responses from the physician recognized GBM "gross tumor volume" (GTV)

Outcome Time Frame:

Upon completion of study

Safety Issue:

No

Principal Investigator

Jonathan Knisely, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Yale University

Authority:

United States: Institutional Review Board

Study ID:

0606001531

NCT ID:

NCT00589095

Start Date:

November 2006

Completion Date:

November 2010

Related Keywords:

  • Glioblastoma Multiforme
  • Glioblastoma

Name

Location
Yale University School Of Medicine New Haven, Connecticut  06520